Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma (Q74664168)
Jump to navigation
Jump to search
scientific article published on 01 February 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma |
scientific article published on 01 February 1999 |
Statements
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma (English)
Sonneveld P
Cornelissen JJ
Joosten P
van Marwijk Kooy M
Meinema J
Nieuwenhuis HK
van Oers MH
Richel DJ
Segeren CN
Veth G
Verdonck LF
1 February 1999